Comparing two hemostatic agents for bleeding during open surgery
This trial tests a new hemostatic agent called ETHIZIA against the standard SURGICEL Original to see if it works better at stopping bleeding from soft tissues during planned open surgeries. If you need a more effective way to control bleeding during your procedure, this study might help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a planned open surgery on your abdomen, pelvis, chest, back, or an arm or leg.
- Your surgeon can see a specific bleeding spot that can't be easily controlled with stitches or a heated tool.
- The bleeding comes from soft tissues (like muscle, fat, or lymph nodes), not from major blood vessels or organs.
- Your bleeding is mild to moderate (not severe or gushing).
- You are not taking multiple blood thinners (except aspirin alone), and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial surveys surgeons about how they use hemostatic agents (medications that stop bleeding during surgery). It aims to understand current practices and improve patient safety.
This trial tests different ways to stop bleeding from bone during finger or toe amputation surgery. It compares using collagen, bone wax, or pressure to see which works best and is safest.
This study tests a special patch called TachoSil against a standard surgical pad (Surgicel) to see which works better for controlling minor oozing during open abdominal, chest, or pelvic surgeries. It may be an option if you are having certain types of surgery and have a small area of mild bleeding that needs help to stop.
This study compares a new stapler (a tool that closes and cuts tissue during surgery) with the standard staplers currently used. It is for people having certain stomach or lung surgeries to see if the new device works as well or better.
This trial tests a method to control bleeding during open heart surgery. It may help you if you are planning to have this surgery.
This study looks at how well a hemostatic (bleeding-stopping) product called PuraBond works during open surgery for an abdominal aortic aneurysm or severe narrowing/blockage of the aorta/iliac arteries. It’s intended for people whose surgeon thinks standard methods may not fully stop bleeding.
Hear when a new Hemostasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.